Author: OurCrowd

This Week In Crowdfunding: How individual investors can invest in top real estate deals

This Week in Crowdfunding is a newly launched podcast series hosted by OurCrowd’s Zack Miller and David Stark, where they cover the best in Crowdfunding with a frank — and educational — discussion about the issues surrounding Crowdfunding. Every week, they interview successful entrepreneurs, deconstruct campaigns, and hear from the smartest people around on this transformative, massive financing trend. Sign up to listen to the podcast on iTunes * Sticher * SoundCloud!  ——————————————— One of the most exciting manifestations of crowdfunding can be found right now in the real estate sector. Investment properties, which were once owned wholly by large real estate firms, are now finding crowdfunding investor interest. And vice versa — individuals, who once struggled to get access to ‘insider’ deals — can now invest in real estate via platforms like Realty Mogul. On this week’s TWiC, hosts Zack Miller and David Stark hosted Realty Mogul’s CEO and founder, Jilliene Helman, to talk about how her firm got off the ground and is now working with both top-flight real estate development projects and attracting investor interest. Watson on Crowdfunding tackles the complicated — but really important — issue of accreditation...

Read More

Where We’ve Been: OurCrowd events quarterly update for July-August-September

It’s been a busy few months at OurCrowd! Throughout July-August-September OurCrowd has hosted numerous events worldwide and we wanted to take a moment to look back at where we were, who we invested in and see where we’re going to be next quarter. We’re so proud of what the OurCrowd community has accomplished over the past three months — from events hosted to the companies funded — and are looking forward to continuing on this journey together in the months to come. Without further ado, here is a glimpse into all the excitement happening at OurCrowd: Where We’ve Been Over the course of the past three months, OurCrowd founder & CEO Jon Medved and team members have traveled the world, hosting various events with the CEOs of our latest startups and guest speakers. We’ve held a total of 14 events, in 10 different cities, across 4 continents! In case you missed them, here are some event highlights: July 1st – Kicking off the quarter, OurCrowd held an exclusive investor event in Paris, France. Hosted by Ayache Salama & Associés, attendees enjoyed a nice...

Read More

GE Ventures makes first investment via equity crowdfunding platform, OurCrowd

We’re proud to announce that MedAware, an OurCrowd portfolio company, has closed its investment of $1 million from GE Ventures and OurCrowd investors. This financing round marks the first investment the venture capital arm of GE, GE Ventures, has made as part of the strategic co-investment partnership OurCrowd signed with the firm back in November 2013. We believe we have reached a real milestone and transformative moment in the world of high-tech finance. This investment underscores the fact that the startup investment playing field is being levelled — OurCrowd investors get access to the same deals multi-billion dollar corporations are seeing, at the same terms. We are looking forward to driving innovation forward with GE Ventures, whose unequalled expertise and experience in a broad range of technologies and businesses add real value to our portfolio companies and to our investor community. “We are excited about the potential for MedAware to solve the huge problem of prescription error via their impressive big data technology,” said Jon Medved, founder and CEO of OurCrowd. “The fact that our partner, General Electric, has joined together with us in...

Read More

OurCrowd’s portfolio company BioCatch featured on Bloomberg TV

OurCrowd portfolio company BioCatch was featured on Bloomberg Television’s “The Pulse.” In the interview, Benny Rosenbaum, Chief Executive Officer at BioCatch, talks with Elliott Gotkine about turning online fraud into art as they visualize the trails left behind by criminals on computers. BioCatch raised $3,334,500 from OurCrowd investors in February 2014. View the video below or play it on Bloomberg...

Read More

OurCrowd’s portfolio company EdenShield featured in The Huffington Post

OurCrowd portfolio company EdenShield was featured in The Huffington Post, a leading online news source, content aggregator and blog. EdenShield are the producers of a novel plant extract from the Israeli Judean Desert that makes crops odorless to pests, preventing multi-billion dollar crop damage. While traditional farmers may be slow to adopt EdenShield’s natural extracts, grown and extracted in Israel and then used on netting in the field or applied in the greenhouse, large grow operations for medical cannabis have been taking note. The team is currently trying their product in Israel and in Africa and are farming the natural substance (plant name is secret) in the northeast Negev Desert. In a kibbutz. They have recently expanded their production from 3 to 30 dunams and are anticipating $1 million USD in sales next year. EdenShield raised $712,000 from OurCrowd investors in 2014. Read more on The Huffington...

Read More